About the Appeal
The campaign to raise £10 million to build a new Translational Cancer Research Centre (TCRC) reached its target in 2012, and the new cutting-edge facility formally opened on 1 May 2014 as the Wolfson Wohl Cancer Research Centre.
The Beatson Pebble Appeal is now in its exciting second phase. Due to strong public support - since August 2012, the appeal has raised over £1.4m – we continue to raise funds to give the new Centre the best possible start, and invest in its ongoing mission. The focus is now on the future, and the prospect of Glasgow being the centre of world-leading breakthroughs in the understanding and treatment of cancer.
The aim of the ongoing appeal is to provide the most up-to-date facilities and equipment, and to help attract world-class cancer research scientists to drive the vital work taking place in Glasgow.
What do cancer scientists hope to achieve in Glasgow?
The key aim of the researchers working at the new Wolfson Wohl Centre is to convert greater scientific knowledge into new treatments. The Centre provides the missing link by shortening the time it takes to translate basic research in the lab into treatment for patients.
The Wolfson Wohl Cancer Research Centre is purpose-designed and built to accelerate the translation of scientific discoveries into improved outcomes for people affected by cancer, and to help define the key research questions of the future.
The ultimate ambition of cancer scientists in Glasgow is to be in a position to treat cancer patients individually, with customised drugs, targeted treatments and diagnostic options that are less toxic and more effective.
With the facilities now in place in Glasgow we are well on our way to achieving our vision. Cancer services in Glasgow serve over 60% of the Scottish population. With a wealth of experience in cancer research and a high incidence of the disease the city is strategically important in the fight against cancer.
Meet the Scientists
Professor Jeff Evans
Professor of Oncology and Director of the
Institute of Cancer Research at the University of Glasgow
“Our vision is to be in a position to treat cancer patients individually, with customised drugs, targeted treatments and diagnostic options that are less toxic and more effective. With the facilities now in place in Glasgow we are well on our way to achieving this goal”
Professor Andrew Biankin
Director of Translational Cancer Research Centre
“Our goal is to give the right treatment, to the right person, at the right time, at the right cost and with the right outcome. Your support of the Beatson Pebble Appeal will ensure we can achieve this vision through the provision of the most advanced facilities and equipment so we can continue to attract the best cancer research scientists in the world.”
Professor Karen Vousden
Director, Beatson Institute
The work of the Beatson TCRC dovetails perfectly with the basic and translational research at the Beatson Institute, and builds on the significant investment and support that the Beatson Institute has received from Cancer Research UK. The new development plays a key role in bringing together basic and clinical research, contributing to the creation of a coordinated cancer research centre and help us develop our discoveries into successful new treatments for cancer patients.'
Professor Hing Leung
Professor of Urology and Medical Oncology
"Seeing is believing: We have witnessed major advances in biomedical research in recent years and I believe that significant improvement to patient care and outcome can be developed. Talents, commitment and cutting edge technologies in the West of Scotland will be enriched now that the translational research centre is built"